Back to News
Market Impact: 0.1
BioArctic Royalty Income Rises 74% As Leqembi Sales Reach JPY 32.2 Bln
Source: Nasdaq
Healthcare & BiotechCorporate Earnings
Eisai reported preliminary global revenue for Leqembi for Q3 2026 in connection with Biogen’s third-quarter earnings release. The article provides no revenue figure or comparison.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Taiwan Stocks Heads for Correction as Global AI Selloff Deepens
- Asia stocks tumble as AI spending concerns deepen; BOJ holds rates
- PC chip plunge wipes out a quarter of Intel’s value